COMPUGEN REPORTS NET LOSS OF $3.0 MIL FOR 2ND QTR 2008.(Financial
report)
Compugen Ltd. (NASDAQ: CGEN), Tel Aviv, Israel, has reported its
results for the second quarter ending June 30, 2008.
Compugen President and CEO Alex Kotzer stated, "During this
past quarter, the . . .
SANGAMO REPORTS NET LOSS OF $7.4 MIL FOR 2ND QTR 2008.(Financial
report)
Sangamo BioSciences, Inc. (NASDAQ:SGMO), Richmond, Calif., has
reported second quarter 2008 financial results and accomplishments.
For the second quarter ended June 30, 2008, Sangamo reported . . .
AVIGEN REPORTS NET LOSS OF $7.3 MIL FOR 2ND QTR 2008.(Financial
report)
Avigen, Inc. (Nasdaq:AVGN), Alameda, Calif., a biopharmaceutical
company innovating therapeutics for neurological care, has reported
financial results for its second quarter ended June 30, 2008. At . . .
GENENTECH GETS $625 MILLION 2ND QTR ROYALTY REVENUE.(Financial
report)
Genentech, Inc., South San Francisco, Calif., (NYSE: DNA) has
announced financial results for the second quarter of 2008. Key results
for the second quarter of 2008 include: U.S. product sales of . . .
GILEAD SCIENCES REPORTS 2ND QTR REVENUES OF $1.28
BILLION.(Financial report)
Gilead Sciences, Inc.(Nasdaq: GILD), Foster City, Calif., has
announced its results of operations for the quarter ended June 30, 2008.
Total revenues for the second quarter of 2008 were $1.28 . . .
CUBIST REPORTS FIRST $100 MILLION REVENUE QUARTER.(Financial
report)
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST), Lexington, Mass., has
reported its first $100 million revenue quarter. For the second quarter
ended June 30, 2008, Cubist's net revenues from CUBICIN . . .
REGENEREX REPORTS 2007 4TH QTR NET LOSS OF $3.5
MILLION.(Financial report)
RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN), Bethesda, Md., has
announced results for the fourth quarter and year ended December 31,
2007. The company reported a net loss of $11.2 million or $0.24 . . .
NEOPHARM REPORTS 2007 4TH QTR NET LOSS OF $1.1 MILLION.(Financial
report)
NeoPharm, Inc. (NASDAQ:NEOL), Waukegan, Ill., has announced its
fourth quarter and full year 2007 financial results.
For the fourth quarter ended December 31, 2007, NeoPharm reported a
net loss . . .
TRANSAVE, INC. RAISES $35 MILLION VIA PREFERRED STOCK.
Transave, Inc., Monmouth Junction, N.J., a biopharmaceutical
company focused on developing innovative inhaled pharmaceuticals for the
site-specific treatment of serious lung diseases has raised an . . .
PURE BIOSCIENCE REPORTS 2ND FISCAL QTR NET LOSS OF
1,553,700.(Financial report)
PURE Bioscience (OTCBB: PURE), San Diego, Calif., has reported
revenues for the second fiscal quarter ended January 31, 2008 of
approximately $152,400 compared with revenues of $168,800 in the . . .
CANTEL MEDICAL REPORTS 18% INCREASE IN SALES FOR 2ND QTR
2008.(Financial report)
Cantel Medical Corp. (NYSE:CMN), Little Falls, N.J., reported
income from continuing operations of $2,157,000, or $0.13 per diluted
share (inclusive of approximately $0.02 of stock-based . . .
BIOMET 2ND QTR FISCAL 2008 NET SALES INCREASED 11%.
Biomet, Inc., Warsaw, Ind., has announced financial results for its
second fiscal quarter ended November 30, 2007.
Worldwide reconstructive device sales increased 15% reported (12%
constant . . .
SAMARITAN ANTICIPATES CONTINUED GROWTH IN 2008.
Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical
company focused on developing innovative therapeutics in the areas of
CNS, cancer, cardiovascular, and infectious diseases, . . .
HAEMACURE REPORTS RECORD REVENUES OF $119,704 IN FISCAL
2007.(Financial report)
Haemacure Corporation (TSX:HAE), a Montreal-based specialty
bio-therapeutics company, has announces the results of the fiscal year
ended October 31, 2007 and provides an update on activities.
. . .
ACCENTIA REPORTS FISCAL 2007 YEAR-END NET LOSS OF $76.0
MIL.(Financial report)
Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), Tampa, Fla., has
announced that the company has filed its Annual Report (Form 10-K) with
the SEC, reporting the results of its operations for the . . .
COVIDIEN REPORTS FISCAL 2007 NET SALES OF $10.2 BILLION.(Company
overview)(Financial report)
Covidien Ltd. (NYSE: COV; BSX: COV), Hamilton, Bermuda, has
reported results for the fourth quarter of fiscal 2007, the first
quarter in which the company operated independent of Tyco . . .
CHINA BIOPHARMACEUTICALS' GROSS PROFIT INCREASES
102%.
China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP) , a
leading Chinese pharmaceutical company focused on the development,
manufacturing and marketing of innovative drugs in China, has . . .
VERTEX REPORTS 2007 3RD QTR NET LOSS OF $107 MILLION.(Financial
report)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), Cambridge,
Mass., has reported consolidated financial results for the quarter ended
September 30, 2007, and the company provided a pipeline . . .
HELIX REPORTS NET LOSS OF $7,674,000 FOR FISCAL 2007.(Financial
report)
Helix BioPharma Corp. (TSX, FSE: "HBP") Aurora, Ont., has
announced financial results for the year ended July 31, 2007. During the
2007 fiscal year, the company continued to make progress with . . .
NUTRITION 21 REPORTS 4TH QTR NET LOSS OF $8.2 MILLION.(Financial
report)
Nutrition 21, Inc. (NASDAQ: NXXI), Purchase, N.Y.,a leading
developer and marketer of chromium-based and omega-3 fish oil- based
nutritional supplements, has announced financial results for the . . .
|
|